In today’s competitive and fast-paced pharmaceutical landscape, specialty pharmacies are emerging as critical partners in the drug development and commercialization process. Their involvement begins well before launch, offering manufacturers vital support during pre-commercialization by helping establish efficient distribution models, identifying patient populations with rare and chronic conditions, and sharing valuable payor and market insights.
Specialty pharmacies bring far more than logistics to small and large manufacturers; they offer a unique combination of clinical expertise, patient-centric services, and actionable real-world data. By aligning closely with a manufacturer’s strategic goals, experienced specialty pharmacies go beyond the traditional “pick, pack, and ship” to accelerate time to market, show a medication’s value proposition beyond clinical trial data, and navigate complex regulatory and reimbursement environments.
Partnership Strategies Overcome Launch Challenges
The steady increase of available specialty medications1 in recent years brings challenges for manufacturers looking to capture maximum market share. And commercializing these medications is no simple task: They require substantial R&D investment, while regulatory pathways and requirements can make development and approval a lengthy process. They also face fierce competition, pricing pressure, and supply chain complexities.
Specialty pharmacies with a high level of expertise can help manufacturers overcome many of these challenges and demonstrate the value of new medications through:
- Pre-commercialization support, such as defining and establishing distribution networks, providing market and payor insights, and acting as a link to providers, payors, and patients.
Specialty pharmacy teams often begin working with manufacturers during Phase 3 drug development, when large-scale studies are conducted to confirm and expand on a medication’s safety and efficacy. During pipeline reviews, the teams may discuss the anticipated launch timeline and explore strategies to accelerate time to market. With input from the specialty pharmacy, manufacturers can define the target patient population and determine whether an open or limited distribution model is most appropriate. When limited distribution is preferred, specialty pharmacies can serve as a vital bridge, offering insights into market conditions, payor dynamics, and stakeholder engagement. - Pre-launch preparation that includes formulary placement, prior authorization and benefits verification, cost-of-care plan analysis, staff training and clinical education, and medication storage arrangements.
When selecting a specialty pharmacy partner, manufacturers consider the pharmacy’s coverage map and accreditations, which support measures such as time to fill, patient adherence, and refrigeration excursion times. Manufacturers may find it advantageous to partner with a specialty pharmacy company that understands the product profile and the unique challenges of the patient population, and has expertise in a specific therapeutic area, such as infusion therapy. - Product awareness and demand creation through provider outreach, payor relationships, and patient education.
To help drive adoption of a medication, specialty pharmacies can leverage their relationships with providers, payors, and patients, communicating that a product exists, what it does, who it benefits, and why it matters. They can help negotiate formulary placement and design reimbursement strategies. Plus, manufacturers who align their HUBs (centralized patient and provider support services) with specialty pharmacies’ patient services enhance the patient experience while increasing demand. - Actionable, timely, real-world data, such as information on patient responses to treatment, adherence measurement, and outcomes.
Many manufacturers assess specialty pharmacies’ data reporting and analytics for quality and accuracy. Actionable data is an essential collaboration element because it can inform manufacturers’ post-marketing surveillance and strategies, inform negotiations with payors, and potentially support label expansion. - Streamlined processes for accelerating access and improving adherence, such as patient support programs, prior authorization support, and ongoing patient monitoring and communication.
Patients using specialty medications face various hurdles, including high costs, complex treatment regimens, and health literacy issues. Experienced specialty pharmacies understand these patient complexities. They are well positioned to handle each patient’s unique treatment journey, including benefits verification, prior authorization, financial assistance, ongoing education, and side effect and adherence monitoring. By helping patients navigate complex insurance barriers and facilitating timely fills, specialty pharmacies can help reduce administrative burden and improve access.
The Patient at the Center
Patient education and communication may be the most important thing a manufacturer looks for in a specialty pharmacy partnership. Manufacturers seek a specialty pharmacy that provides all the care and services needed to ensure the patient starts and stays on therapy. What sets a highly experienced specialty pharmacy apart is well-implemented patient support services that go beyond receiving, filling, and distributing prescriptions to achieve sustained adherence and positive outcomes.
While streamlining insurance coverage, co-pay programs, and pre-authorization processes are all important value-adds, the best specialty pharmacies also offer broad patient support, understanding that educated patients are more likely to adhere to treatment. In collaboration with the manufacturer, specialty pharmacies can provide patients with information about their disease or condition and help them understand the benefits of certain medications.
Developing strong relationships with the patients they serve is paramount for any specialty pharmacy. At Acelpa Health’s specialty pharmacies, pharmacists, nurses, and care coordinators are readily available to answer questions and support patients in need. We offer online information, videos, 24/7 support, and printed materials to support the patient journey. We also tailor patient risk assessments and regular communication for each patient, with a regular cadence of targeted communication to monitor adherence and side effects.
When specialty pharmacies and manufacturers strengthen their collaboration around new medication launches and prioritize patient education, the result is quicker access, cost efficiencies, better adherence, and improved outcomes for those with complex conditions.
1 Advancing Health Through Innovation: New Drug Therapy Approvals 2023. https://www.fda.gov/media/175253/download?attachment